← Browse by Condition
Medical Condition
head and neck squamous cell carcinoma hnscc
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for head and neck squamous cell carcinoma hnscc sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — head and neck squamous cell carcinoma hnscc Clinical Trials
How many clinical trials are currently recruiting for head and neck squamous cell carcinoma hnscc?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for head and neck squamous cell carcinoma hnscc, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for head and neck squamous cell carcinoma hnscc?
head and neck squamous cell carcinoma hnscc research spans Phase 1 (4 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a head and neck squamous cell carcinoma hnscc clinical trial?
Eligibility criteria for head and neck squamous cell carcinoma hnscc trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 4
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06794372 Phase 2
Recruiting
Enrollment
20 pts
Location
Switzerland
Sponsor
John O. Prior
NCT05473156 Phase 1, Phase 2
Recruiting
Enrollment
168 pts
Location
Taiwan
Sponsor
AP Biosciences Inc.
NCT05985655 Phase 1, Phase 2
Recruiting
Enrollment
230 pts
Location
United States, Belgi...
Sponsor
Exscientia AI Ltd., a wholly o...
NCT07190755
Recruiting
Enrollment
192 pts
Location
France
Sponsor
Centre Henri Becquerel
NCT07457281 Phase 1
Recruiting
Enrollment
9 pts
Location
China
Sponsor
West China Hospital
NCT06797986 Phase 1, Phase 2
Recruiting
Enrollment
37 pts
Location
South Korea
Sponsor
Cellid Co., Ltd.
NCT06630780
Recruiting
Enrollment
50 pts
Location
China
Sponsor
Sun Yat-sen University
Related Conditions
non small cell lung cancer nsclc (2) locally advanced or metastatic solid tumors (1) esophageal squamous cell carcinoma escc (1) pancreatic adenocarcinoma (1) platinum resistant high grade epithelial ovarian primary peritoneal or fallopian tube cancers hgsoc (1) hormone receptor positive hr and human epidermal growth factor receptor 2 negative her2 breast carcinoma (1) triple negative breast cancer tnbc (1) hpv human papillomavirus associated carcinoma (1) hpv positive oropharyngeal squamous cell carcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology